Legato Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $977K | Hold |
40,863
| – | – | 0.12% | 281 |
|
|
2025
Q1 | $1.02M | Sell |
40,863
-14,040
| -26% | -$349K | 0.14% | 246 |
|
|
2024
Q4 | $1.03M | Hold |
54,903
| – | – | 0.14% | 285 |
|
|
2024
Q3 | $826K | Buy |
54,903
+1,990
| +4% | +$29.9K | 0.1% | 351 |
|
|
2024
Q2 | $1.51M | Buy |
52,913
+22,497
| +74% | +$644K | 0.2% | 174 |
|
|
2024
Q1 | $889K | Buy |
30,416
+19,248
| +172% | +$562K | 0.11% | 302 |
|
|
2023
Q4 | $377K | Buy |
11,168
+1,563
| +16% | +$52.7K | 0.05% | 468 |
|
|
2023
Q3 | $295K | Buy |
+9,605
| New | +$295K | 0.04% | 480 |
|